Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab

Stopped Unable to get materials from GE, study not proceeding and never opened to accrual

Conditions

• Glioblastoma Multiforme (GBM)

Interventions

• DRUG: Fluciclitite , PET imaging, and Bevacizumab

Sponsor

University of Utah